...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith AGM Tuesday 12/12 2:45 MT
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Here is the link to the slide deck from today, which can also be found on the Zenith Presentations Page.

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply